Form 13-F position report

ORCHARD THERAPEUTICS PLC ADS N

Reported by Skandinaviska Enskilda Banken AB publ

ORTX CUSIP 68570P200 Manager CIK 0001534653

Reported 0 shares, down 140,500 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q1 2024
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 2 Through Q1 2024

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2023-12-31 2311225
2024-03-31 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

2 quarters
Quarterly reported position history for ORCHARD THERAPEUTICS PLC ADS N held by Skandinaviska Enskilda Banken AB publ.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q1 2024 Reduced 0 -140,500 (-100.0%) 0 $0 2024-05-13
Q4 2023 New 140,500 +140,500 (0.0%) 0.01% $2,311,225 2024-02-14

Who else reported the position

47 managers reported ORCHARD THERAPEUTICS PLC ADS N for Q1 2024.

Managers reporting ORCHARD THERAPEUTICS PLC ADS N in Q1 2024.
Manager Activity Shares Change % of reported 13F Reported value Tenure
TUDOR INVESTMENT CORP ET AL Reduced 0 -300,000 0 $0 2 qtrs
FEDERATED HERMES INC Reduced 0 -869,327 0 $0 5 qtrs
ADAR1 Capital Management LLC Reduced 0 -63,622 0 $0 2 qtrs
HARVEST MANAGEMENT LLC Reduced 0 -10,000 0 $0 2 qtrs
PenderFund Capital Management Ltd Reduced 0 -23,580 0 $0 2 qtrs
Compass Wealth Management LLC Reduced 0 -9 0 $0 2 qtrs
FMR LLC Reduced 0 -41,228 0 $0 5 qtrs
JPMorgan Chase & Co Reduced 0 -27,184 0 $0 5 qtrs
LMR Partners LLP Reduced 0 -332,223 0 $0 2 qtrs
UBS Group AG Reduced 0 -380 0 $0 5 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
March 31, 2024
Filed
May 13, 2024
Filing type
13F-HR
Position type
SPON ADS NEW

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.